Obstet Gynecol. 2003 Aug;102(2):417-27. doi: 10.1016/s0029-7844(03)00745-2.
Although cervical cancer was the leading cause of cancer death in American women as recently as the 1930s, both the incidence and mortality from cervical cancer have decreased by almost one half since the early 1970s, largely as a result of widespread screening with the Pap test. However, the annual incidence rate has remained at approximately 8 cases per 100,000 women over the past few years. New technology for performing cervical cytology is evolving rapidly as are recommendations for classifying and interpreting the results. The purpose of this document is to provide a review of the best available evidence on screening for cervical cancer. Specific equipment and techniques for performing cervical cytology and interpretation of the results are discussed elsewhere.
尽管直到20世纪30年代宫颈癌仍是美国女性癌症死亡的主要原因，但自20世纪70年代初以来，宫颈癌的发病率和死亡率均下降了近一半，这主要归功于巴氏试验的广泛筛查。然而，在过去几年中，年发病率仍保持在每10万名女性约8例。用于进行宫颈细胞学检查的新技术正在迅速发展，对检查结果进行分类和解读的建议也是如此。本文的目的是对宫颈癌筛查的现有最佳证据进行综述。进行宫颈细胞学检查的具体设备和技术以及结果解读在其他地方讨论。
